Company Filing History:
1 out of 20 
1 out of 6 Years Active: 2019
Title: The Innovations of Nam Jo Park
Introduction
Nam Jo Park is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in vaccine development. His work focuses on innovative methods for producing vaccines using plant-based systems.
Latest Patents
Nam Jo Park holds a patent for a vaccine composition for classical swine fever derived from plants. The patent describes a recombinant vector designed for transforming plants, which enables the production of a plant-made classical swine fever virus antigen, specifically the pmE2 protein. This method offers high efficiency and enhanced safety and stability compared to traditional production methods. The plant-derived antigen also features a cellulose-binding domain protein, which serves as an effective marker for tracking virus exposure and antibody production pathways.
Career Highlights
Throughout his career, Nam Jo Park has worked with various organizations, including Bioapplications Inc. and the Republic of Korea's Animal and Plant Quarantine Agency. His experience in these institutions has allowed him to advance his research and contribute to the field of agricultural biotechnology.
Collaborations
Nam Jo Park has collaborated with notable colleagues, including Dong Jun An and Seong In Lim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his innovative work.
Conclusion
Nam Jo Park's contributions to vaccine development through plant-based systems highlight the potential of biotechnology in addressing agricultural challenges. His innovative approaches continue to pave the way for advancements in the field.